 Rajratan Global Wire Ltd Q2FY26 consolidated net profit increases to Rs. 20.55 crores
Rajratan Global Wire Ltd Q2FY26 consolidated net profit increases to Rs. 20.55 crores Xchanging Solutions Ltd Q2 FY2026 consolidated PAT climbs to Rs. 16.26 crores
Xchanging Solutions Ltd Q2 FY2026 consolidated PAT climbs to Rs. 16.26 crores Cipla Ltd consolidated Q2FY26 net profit increases to Rs. 1351.17 crores
Cipla Ltd consolidated Q2FY26 net profit increases to Rs. 1351.17 crores Bhansali Engineering Polymers Ltd Q2 FY2025-26 net profit at Rs. 40.45 crores
Bhansali Engineering Polymers Ltd Q2 FY2025-26 net profit at Rs. 40.45 crores Valiant Communications Ltd Q2 FY2026 consolidated profit at Rs. 5.26 crores
Valiant Communications Ltd Q2 FY2026 consolidated profit at Rs. 5.26 crores 
              The Initial Public Offering of SMS Pharmaceuticals Ltd which closed on Thursday (February 8, 2007)has received subscription of 2.64 times. The company came out with an IPO of 2,577,000 Equity Shares of Rs.10 each for cash at par in a price band of Rs.360/- to Rs.380/- through 100% book building process.
The Qualified Institutional Buyers (QIBs) portion of the issue received subscription for 4470300 resulting in a subscription of 3.4694 times, Non Institutional Investors portion received bids for just 109755 equity shares resulting in a meagre subscription of 0.2839 times and the Retail Individual Investors (RIIs) portion received bids for 2.4715 times (2229165 shares).
UTI Securities Ltd is the Book Running Lead Manager for the issue. AARTHI CONSULTANTS PVT LTD is the Registrar to the Issue.
Out of the issue, 1,288,500 equity shares have been reserved for Qualified Institutional Buyers (QIBs), 386,550 shares for Non Institutional Investors and 901,950 shares for Retail Individual Investors (RIIs).
The company's website is SMS Pharmaceuticals Ltd
Click on the link for company's IPO prospectus SMS Pharmaceuticals Ltd Prospectus